Annual EBITDA
-$24.70 M
-$4.56 M-22.63%
December 1, 2023
Summary
- As of February 12, 2025, ACTU annual EBITDA is -$24.70 million, with the most recent change of -$4.56 million (-22.63%) on December 1, 2023.
- During the last 3 years, ACTU annual EBITDA has fallen by -$4.56 million (-22.63%).
- ACTU annual EBITDA is now -22.63% below its all-time high of -$20.14 million, reached on December 1, 2022.
Performance
ACTU EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$5.97 M
+$599.60 K+9.13%
September 1, 2024
Summary
- As of February 12, 2025, ACTU quarterly EBITDA is -$5.97 million, with the most recent change of +$599.60 thousand (+9.13%) on September 1, 2024.
- Over the past year, ACTU quarterly EBITDA has increased by +$599.60 thousand (+9.13%).
- ACTU quarterly EBITDA is now -13.84% below its all-time high of -$5.24 million, reached on March 1, 2023.
Performance
ACTU Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$28.43 M
+$365.40 K+1.27%
September 1, 2024
Summary
- As of February 12, 2025, ACTU TTM EBITDA is -$28.43 million, with the most recent change of +$365.40 thousand (+1.27%) on September 1, 2024.
- Over the past year, ACTU TTM EBITDA has increased by +$365.40 thousand (+1.27%).
- ACTU TTM EBITDA is now -442.42% below its all-time high of -$5.24 million, reached on March 1, 2023.
Performance
ACTU TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ACTU EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.6% | +9.1% | +1.3% |
| 3 y3 years | -22.6% | +9.1% | +1.3% |
| 5 y5 years | -22.6% | +9.1% | +1.3% |
ACTU EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -22.6% | at low | -13.8% | +28.0% | -442.4% | +1.3% |
| 5 y | 5-year | -22.6% | at low | -13.8% | +28.0% | -442.4% | +1.3% |
| alltime | all time | -22.6% | at low | -13.8% | +28.0% | -442.4% | +1.3% |
Actuate Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.97 M(-9.1%) | -$28.43 M(-1.3%) |
| Jun 2024 | - | -$6.57 M(-20.8%) | -$28.80 M(+3.8%) |
| Mar 2024 | - | -$8.29 M(+9.0%) | -$27.75 M(+12.3%) |
| Dec 2023 | -$24.70 M | -$7.61 M(+20.1%) | -$24.70 M(+44.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$6.33 M(+14.7%) | -$17.09 M(+58.9%) |
| Jun 2023 | - | -$5.52 M(+5.3%) | -$10.76 M(+105.3%) |
| Mar 2023 | - | -$5.24 M | -$5.24 M |
| Dec 2022 | -$20.14 M | - | - |
FAQ
- What is Actuate Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Actuate Therapeutics?
- What is Actuate Therapeutics annual EBITDA year-on-year change?
- What is Actuate Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Actuate Therapeutics?
- What is Actuate Therapeutics quarterly EBITDA year-on-year change?
- What is Actuate Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Actuate Therapeutics?
- What is Actuate Therapeutics TTM EBITDA year-on-year change?
What is Actuate Therapeutics annual EBITDA?
The current annual EBITDA of ACTU is -$24.70 M
What is the all time high annual EBITDA for Actuate Therapeutics?
Actuate Therapeutics all-time high annual EBITDA is -$20.14 M
What is Actuate Therapeutics annual EBITDA year-on-year change?
Over the past year, ACTU annual EBITDA has changed by -$4.56 M (-22.63%)
What is Actuate Therapeutics quarterly EBITDA?
The current quarterly EBITDA of ACTU is -$5.97 M
What is the all time high quarterly EBITDA for Actuate Therapeutics?
Actuate Therapeutics all-time high quarterly EBITDA is -$5.24 M
What is Actuate Therapeutics quarterly EBITDA year-on-year change?
Over the past year, ACTU quarterly EBITDA has changed by +$599.60 K (+9.13%)
What is Actuate Therapeutics TTM EBITDA?
The current TTM EBITDA of ACTU is -$28.43 M
What is the all time high TTM EBITDA for Actuate Therapeutics?
Actuate Therapeutics all-time high TTM EBITDA is -$5.24 M
What is Actuate Therapeutics TTM EBITDA year-on-year change?
Over the past year, ACTU TTM EBITDA has changed by +$365.40 K (+1.27%)